한빛사
>
한빛사논문
한빛사논문
- 조회481
Adv. Healthc. Mater., Apr 03 2024, | https://doi.org/10.1002/adhm.202400235
Antibody-Conjugated Nanogel with Two Immune Checkpoint Inhibitors for Enhanced Cancer Immunotherapy
Yun Jin Chae 1, Kang-Gon Lee 2, Doogie Oh 2, Su-Kyoung Lee 1, Yongdoo Park 2, Jongseong Kim 2
1R&D center, Scholar Foxtrot Co. Ltd., Seoul, 02796, Republic of Korea.
2Department of Biomedical Sciences, College of Medicine, Korea University, Seoul, 02841, Republic of Korea.
Y. J. C., K. L., and D. O.contributed equally to this work.
CORRESPONDING AUTHORS : Yongdoo Park, Jongseong Kim
Abstract
Cancer immunotherapy by immune checkpoint inhibitors (ICIs) acts on antitumor responses by stimulating the immune system to attack cancer cells. However, this powerful therapy is hampered by its high treatment cost and limited efficacy. Here, it is shown that the development of an Antibody-conjugated NanoGel (ANGel), consisting of N-isopropylacrylamide-co-acrylic acid and antibody-binding protein (protein A), that potentiates the efficacy of two ICI mAbs (CTLA-4 and PD-L1 mAbs). Compared with mAb treatment alone, treatment with a bispecific ANGel surface-conjugated with the mAbs significantly decreases both the survival of MCF-7 and MDA-MB-231 breast cancer cells in vitro and the burden of 4T1-Luc2-derived orthotopic syngeneic tumors in vivo. The bispecific ANGel is also more potent than the conventional treatment at prolonging survival in animals with triple-negative breast cancer (TNBC). The advantage of the bispecific ANGel over other engineered bispecific antibodies arises not only from the adaptability to link multiple antibodies quickly and easily, but also from the capability to maintain the anticancer effect steadily at subcutaneously delivered tumor site. Our finding has an important implication for cancer immunotherapy, opening a new paradigm to treat solid tumors. This article is protected by copyright. All rights reserved.
논문정보
- Research article
- 2024년 04월 (BRIC 등록일 2024-04-04)
- 국내 연구진
- 바이오·의료융합 > 바이오센싱 및 나노바이오물질
댓글 작성 로그인
팝업 닫기관련 링크
관련분야 연구자보기
소속기관 논문보기
관련분야 논문보기
